文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

2020 年加拿大癌症预估。

Projected estimates of cancer in Canada in 2020.

机构信息

Departments of Oncology and Community Health Sciences (Brenner), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Division of Cancer Prevention and Control (Weir), Centers for Disease Control and Prevention, Atlanta, Ga.; Centre for Surveillance and Applied Research (Demers, Shaw), Public Health Agency of Canada; Centre for Population Health Data (Ellison), Statistics Canada, Ottawa, Ont.; Data Linkage and Integration (Louzado), Canadian Partnership Against Cancer, Toronto, Ont.; Population Oncology (Turner), CancerCare Manitoba, Winnipeg, Man.; Population Oncology (Woods), BC Cancer, Vancouver, BC; Canadian Cancer Society (Smith), St. John's, N.L.

出版信息

CMAJ. 2020 Mar 2;192(9):E199-E205. doi: 10.1503/cmaj.191292.


DOI:10.1503/cmaj.191292
PMID:32122974
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7055947/
Abstract

BACKGROUND: Cancer projections to the current year help in policy development, planning of programs and allocation of resources. We sought to provide an overview of the expected incidence and mortality of cancer in Canada in 2020 in follow-up to the report. METHODS: We obtained incidence data from the National Cancer Incidence Reporting System (1984-1991) and Canadian Cancer Registry (1992-2015). Mortality data (1984-2015) were obtained from the Canadian Vital Statistics - Death Database. All databases are maintained by Statistics Canada. Cancer incidence and mortality counts and age-standardized rates were projected to 2020 for 23 cancer types by sex and geographic region (provinces and territories) for all ages combined. RESULTS: An estimated 225 800 new cancer cases and 83 300 cancer deaths are expected in Canada in 2020. The most commonly diagnosed cancers are expected to be lung overall (29 800), breast in females (27 400) and prostate in males (23 300). Lung cancer is also expected to be the leading cause of cancer death, accounting for 25.5% of all cancer deaths, followed by colorectal (11.6%), pancreatic (6.4%) and breast (6.1%) cancers. Incidence and mortality rates will be generally higher in the eastern provinces than in the western provinces. INTERPRETATION: The number of cancer cases and deaths remains high in Canada and, owing to the growing and aging population, is expected to continue to increase. Although progress has been made in reducing deaths for most major cancers (breast, prostate and lung), there has been limited progress for pancreatic cancer, which is expected to be the third leading cause of cancer death in Canada in 2020. Additional efforts to improve uptake of existing programs, as well as to advance research, prevention, screening and treatment, are needed to address the cancer burden in Canada.

摘要

背景:对当年癌症数据的预测有助于政策制定、项目规划和资源分配。本研究旨在对 2017 年报告进行补充,概述 2020 年加拿大癌症发病和死亡情况。

方法:我们从国家癌症发病率报告系统(1984-1991 年)和加拿大癌症登记处(1992-2015 年)获得发病率数据。死亡率数据(1984-2015 年)来自加拿大生命统计-死亡数据库。所有数据库均由加拿大统计局维护。我们根据性别和地理区域(省份和地区)对所有年龄组人群的 23 种癌症类型的发病和死亡数据进行了统计,并计算了年龄标准化发病率,结果预测到 2020 年。

结果:预计 2020 年加拿大将有 225 800 例新发癌症病例和 83 300 例癌症死亡病例。预计最常见的癌症包括:肺癌(29 800 例)、女性乳腺癌(27 400 例)和男性前列腺癌(23 300 例)。肺癌预计仍是癌症死亡的主要原因,占所有癌症死亡的 25.5%,其次是结直肠癌(11.6%)、胰腺癌(6.4%)和乳腺癌(6.1%)。东部省份的发病率和死亡率一般高于西部省份。

结论:加拿大的癌症发病和死亡人数仍然居高不下,且由于人口不断增长和老龄化,预计这一数字还将继续上升。尽管在降低大多数主要癌症(乳腺癌、前列腺癌和肺癌)的死亡率方面已取得一定进展,但胰腺癌的进展有限,预计其将成为 2020 年加拿大第三大癌症死亡原因。为了应对加拿大的癌症负担,需要进一步努力提高现有项目的参与度,并推进癌症研究、预防、筛查和治疗。

相似文献

[1]
Projected estimates of cancer in Canada in 2020.

CMAJ. 2020-3-2

[2]
Projected estimates of cancer in Canada in 2022.

CMAJ. 2022-5-2

[3]
Projected estimates of cancer in Canada in 2024.

CMAJ. 2024-5-12

[4]
1992 Canadian Cancer Statistics.

Health Rep. 1992

[5]
Long-term projections of cancer incidence and mortality in Canada: The OncoSim All Cancers Model.

Prev Med. 2023-3

[6]
The future burden of cancer in Canada: Long-term cancer incidence projections 2013-2042.

Cancer Epidemiol. 2019-3-1

[7]
Cancer incidence and mortality across Canada.

Health Rep. 1998

[8]
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.

Epidemiol Prev. 2016

[9]
Prediction of Cancer Incidence and Mortality in Korea, 2024.

Cancer Res Treat. 2024-4

[10]
Cancer incidence in Canada: trends and projections (1983-2032).

Health Promot Chronic Dis Prev Can. 2015

引用本文的文献

[1]
Assessing colorectal cancer screening and outcomes among First Nations people in Alberta.

J Can Assoc Gastroenterol. 2025-3-18

[2]
Explainable one-class feature extraction by adaptive resonance for anomaly detection in quality assurance.

PLoS One. 2025-6-10

[3]
The m6A methyltransferase METTL3 affects ferroptosis in non-small cell lung cancer by regulating the PTEN/PI3K/AKT pathway.

Discov Oncol. 2025-4-18

[4]
Feasibility, Acceptability, and Potential Effects of a Digital Oral Anticancer Agent Intervention: Protocol for a Pilot Randomized Controlled Trial.

JMIR Res Protoc. 2025-3-26

[5]
Dysplasia and Malignancy in Colonic Polyps: Preparing for a Resect and Discard Strategy in Canada.

JGH Open. 2025-3-18

[6]
Prehabilitation Program for Lung and Esophageal Cancers (Boosting Recovery and Activity Through Early Wellness): Protocol for a Nonrandomized Trial.

JMIR Res Protoc. 2025-3-10

[7]
Workforce Trends Among Canadian Medical Oncologists and Medical Oncology Trainees over Two Decades.

Curr Oncol. 2025-1-28

[8]
Feasibility and acceptability of a personalised primary prevention strategy for women and men at high risk of breast and prostate cancer: the 3PC study protocol for a pilot randomised controlled trial.

BMJ Open. 2025-2-17

[9]
On the path toward cervical cancer elimination in Canada: a national survey of factors influencing women's intentions to participate in human papillomavirus test-based primary cervical screening.

Lancet Reg Health Am. 2024-10-15

[10]
Supplemental Screening as an Adjunct to Mammography for Breast Cancer Screening in People With Dense Breasts: A Health Technology Assessment.

Ont Health Technol Assess Ser. 2023

本文引用的文献

[1]
National Trends in Colorectal Cancer Incidence Among Older and Younger Adults in Canada.

JAMA Netw Open. 2019-7-3

[2]
Recent trends in prostate cancer in Canada.

Health Rep. 2019-4-17

[3]
Cancer statistics, 2019.

CA Cancer J Clin. 2019-1-8

[4]
Progress in net cancer survival in Canada over 20 years.

Health Rep. 2018-9-19

[5]
Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations.

Prostate Cancer Prostatic Dis. 2018-8-21

[6]
Targeted therapy for metastatic colorectal cancer.

Expert Rev Anticancer Ther. 2018-8-3

[7]
Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics.

Cancer. 2018-5-22

[8]
Cancer statistics, 2018.

CA Cancer J Clin. 2018-1-4

[9]
The economic burden of cancer care in Canada: a population-based cost study.

CMAJ Open. 2018-1-4

[10]
Abiraterone in Metastatic Prostate Cancer.

N Engl J Med. 2017-10-26

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索